News Blonder Tongue Laboratories, Inc.

Equities

BDRL

US0936981085

Delayed OTC Markets Other stock markets 10:58:06 2024-05-13 am EDT			5-day change	1st Jan Change
0.1141 ^USD	-12.24%		-12.23%	+40.00%

2023	Blonder Tongue Announces IP Failover Feature Added to NXG Video Delivery System	CI
2023	Tranche Update on Blonder Tongue Laboratories, Inc.'s Equity Buyback Plan announced on February 13, 2007.	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Blonder Tongue Announces IP Failover Feature Added to NXG Video Delivery System	Nov. 06	CI
BLONDER TONGUE LABORATORIES INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	23-04-17	AQ
Tranche Update on Blonder Tongue Laboratories, Inc.'s Equity Buyback Plan announced on February 13, 2007.	23-04-17	CI
Tranche Update on Blonder Tongue Laboratories, Inc.'s Equity Buyback Plan announced on July 24, 2002.	23-04-17	CI
Blonder Tongue Laboratories, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-17	CI
Blonder Tongue Laboratories, Inc. Auditor Raises 'Going Concern' Doubt	23-04-16	CI
BLONDER TONGUE LABORATORIES INC : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	23-03-01	AQ
Blonder Tongue Announces Demise of Eric Skolnik, Senior Vice President	23-02-23	CI
Blonder Tongue Announces Demise of Eric Skolnik, Chief Financial Officer; Appoints Michael Censoplano as Interim CFO	23-02-23	CI
BLONDER TONGUE LABORATORIES INC : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	23-02-13	AQ
Blonder Tongue Laboratories, Inc. Announces the Retirement of Stephen K. Necessary from the Board	23-02-13	CI
BLONDER TONGUE LABORATORIES INC : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	23-01-23	AQ
Blonder Tongue Laboratories, Inc. Announces President Changes	23-01-23	CI
Blonder Tongue Laboratories, Inc. Announces Chief Executive Officer Changes	23-01-23	CI
BLONDER TONGUE LABORATORIES INC : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	23-01-06	AQ
BLONDER TONGUE LABORATORIES INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	22-11-04	AQ
Tranche Update on Blonder Tongue Laboratories, Inc.'s Equity Buyback Plan announced on July 24, 2002.	22-11-04	CI
Tranche Update on Blonder Tongue Laboratories, Inc.'s Equity Buyback Plan announced on February 13, 2007.	22-11-04	CI
Transcript : Blonder Tongue Laboratories, Inc., Q3 2022 Earnings Call, Nov 04, 2022	22-11-04
Blonder Tongue Laboratories, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-04	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Blonder Tongue Laboratories, Inc.

Equities

BDRL

US0936981085

Summary

Filters